These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9503530)

  • 81. [The changes of lipids, lipoproteins and apolipoproteins in plasma in ischemic stroke].
    Barkhatova VP; Suslina ZA; Ionova VG; Chudakova IA; Mel'kina OE; Tanashian MM; Rebrova OIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(8):34-8. PubMed ID: 9752680
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Clinical and metabolic effects of biological active food additives--phospholipids--in patients with cardiovascular diseases].
    Samsonov MA; Vasil'ev AV; Pokrovskaia GR; Pogozheva AV; Moskvicheva IuB; Timofeenko TI; Kornena EP
    Vopr Pitan; 1997; (3):35-8. PubMed ID: 9289919
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Composition of plasma lipoproteins and clinical indicators of the progression of arteriosclerosis in patients with primary hyperlipoproteinemia and different degrees of lipid change in the soft palate].
    Markiewicz M; Dubejko J; Rymar B; Koziara Z; Horubała-Bielak G
    Wiad Lek; 1984 Jun; 37(11):831-5. PubMed ID: 6506704
    [No Abstract]   [Full Text] [Related]  

  • 84. [Changes in the fat-acid spectrum of high-density lipoproteins as observed in men and women with acute appendicitis].
    Osochuk SS; Konevalova NIu
    Klin Lab Diagn; 2005 Jan; (1):8-11. PubMed ID: 15765644
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [The prognostic significance of cholesterol determination in the high-density lipoprotein fraction of blood donors].
    Kurashvili LV; Volkov AS
    Gematol Transfuziol; 1993 May; 38(5):39-40. PubMed ID: 8034173
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The effect of I.V. glucagon administration on selected metabolic parameters in patients with type IIa, IIb and IV primary hyperlipoproteinaemia.
    Andĕl M; Brodan V; Kucerová L; Brodanová M
    Acta Univ Carol Med (Praha); 1980; 26(5-6):271-92. PubMed ID: 7347126
    [No Abstract]   [Full Text] [Related]  

  • 87. [Some aspects of the metabolic interrelationship between plasma lipoproteins and cells (author's transl)].
    Wehr H
    Postepy Biochem; 1980; 26(2):139-59. PubMed ID: 7001416
    [No Abstract]   [Full Text] [Related]  

  • 88. Alterations in cholesterol metabolism in the genetically hypercholesterolemic RICO rat: an overview.
    Ouguerram K; Magot T; Lutton C
    Adv Exp Med Biol; 1991; 285():257-74. PubMed ID: 1858555
    [No Abstract]   [Full Text] [Related]  

  • 89. [Effect of calcium pangamate on the cholesterol index of atherogenicity in cerebral arteriosclerosis patients].
    Rastopchin IP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1020-3. PubMed ID: 6475410
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Clinical characteristics of primary hyperlipoproteinemia type IV. An analysis of 86 patients].
    Kusić M; Gavrilović M; Mihajlović M; Marković N
    Zb Vojnomed Akad; 1981; 23():15-9. PubMed ID: 6963834
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [The lipid composition of high-density lipoproteins in patients with psoriasis].
    Kurnikov GIu; Abalikhina EP; Kopytova TV; Tvorogova MG
    Klin Lab Diagn; 2003 Nov; (11):16-9. PubMed ID: 14708366
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Alphalipoproteinemia: evaluation of the utility of its determination].
    Quintão EC
    Arq Bras Cardiol; 1980 Apr; 34(4):263-5. PubMed ID: 7436783
    [No Abstract]   [Full Text] [Related]  

  • 93. [Long-term effect of polyenic-fatty-acids-enriched diet on the relations of fatty acids and glycerophospholipids in 50- to 60-year-old HLP patients].
    Reuter W; Heybey U
    Z Alternsforsch; 1984; 39(2):63-6. PubMed ID: 6730529
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Peroxide-induced damage to high-density lipoproteins and their cholesterol-acceptor function in patients with ischemic heart disease and in healthy people].
    Plavinskiĭ SL; Kuznetsov AS
    Fiziol Cheloveka; 1997; 23(1):103-7. PubMed ID: 9162643
    [No Abstract]   [Full Text] [Related]  

  • 95. Cholesteryl sulfate: measurement with beta-sitosteryl sulfate as an internal standard.
    Huang YS; Eid K; Davignon J
    Can J Biochem; 1981 Aug; 59(8):602-5. PubMed ID: 7296344
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Experiences using long-term (4-12 months) plasmapheresis in patients with hereditary hypercholesterolemia].
    Kukharchuk VV; Konovalov GA; Kurdanov KhA; Perova NV; Vedernikov AIu
    Kardiologiia; 1986 Oct; 26(10):19-23. PubMed ID: 3795695
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The receptor model for transport of cholesterol in plasma.
    Brown MS; Goldstein JL
    Ann N Y Acad Sci; 1985; 454():178-82. PubMed ID: 3907461
    [No Abstract]   [Full Text] [Related]  

  • 98. Quantification of amounts of coronary arterial narrowing in patients with types II and IV hyperlipoproteinemia and in those with known normal lipoprotein patterns.
    Cabin HS; Roberts WC
    Am Heart J; 1981 Jan; 101(1):52-8. PubMed ID: 7457340
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Familial hyperlipidemia in stroke in the young.
    Bansal BC; Sood AK; Bansal CB
    Stroke; 1986; 17(6):1142-5. PubMed ID: 3810712
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Prostacyclin synthesis stimulating plasma factor in patients with primary hyperlipoproteinemia--effect of dietary and drug treatment.
    Sinzinger H; Kaliman J; Strobl-Jäger E; Widhalm K; Peskar BA
    Prostaglandins Leukot Med; 1986 May; 22(2):179-89. PubMed ID: 3523539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.